Unanswered Questions Regarding Blood Pressure Management for HF Prevention

AbstractPurpose of ReviewEvaluate the relevant new findings regarding hypertension treatment and heart failure prevention published in the past 3  years.Recent FindingsIn a recent secondary analysis of Systolic Blood Pressure Intervention Trial (SPRINT), randomization of more than 9000 patients>  50 years old with high cardiovascular risk but without diabetes to intensive treatment targeting blood pressure<  120/80 mmHg compared to standard treatment targeting<  140/90 mmHg significantly reduced incident heart failure. While such benefits outweighed potential harm, adverse events including renal dysfunction, hypotension, and syncope occurred more frequently with intensive treatment. Following SPRINT, existing guidelines differ in their recommendations a nd controversies still exist. Key persistent questions include the role of intensive treatment in younger adults and those at lower cardiovascular risk and optimal approaches to translate clinical trial findings into clinical practice in a sustainable fashion.SummaryAggressively treating hypertension to targets below 120/80  mmHg prevents heart failure in high-risk patients. However, evidence is lacking to younger patients and those at lower cardiovascular risk.
Source: Current Hypertension Reports - Category: Primary Care Source Type: research